The risks of opting out of the landmark BCBS antitrust settlement
The Blue Cross Blue Shield antitrust settlement offers healthcare providers $2.8 billion in compensation and systemic BlueCard improvements, with opting out posing significant risks of costly, prolonged litigation and forfeiture of transformative benefits.
Beyond the payout: How the BCBS antitrust settlement will transform the BlueCard program for providers
The recent $2.8 billion Blue Cross Blue Shield antitrust settlement, coupled with mandated system improvements, promises to address long-standing issues with the BlueCard system, ensuring more timely payments, increased transparency, and reduced administrative burdens for healthcare providers.